Overruling uncertainty about preventative medications: the social organisation of healthcare professionals' knowledge and practices. by Cupit, Caroline et al.
Overruling uncertainty about preventative medications:
the social organisation of healthcare professionals’
knowledge and practices
Caroline Cupit1 , Janet Rankin2, Natalie Armstrong1
and Graham P. Martin1,3
1SAPPHIRE Group, College of Life Sciences, University of Leicester, Leicester, UK
2Faulty of Nursing, University of Calgary, Calgary, Canada
3THIS Institute (The Healthcare Improvement Studies Institute), University of Cambridge
Primary Care Unit, Cambridge, UK
Abstract In this article, we draw on an institutional ethnographic (IE) study of
cardiovascular disease prevention in general practice, exploring the work of
healthcare professionals who introduce a discussion of risk and preventative
medications into consultations with patients. Our aim is to explicate, using IE’s
theoretical ontology and analytical tools, how troubling patient experiences in this
clinical context are coordinated institutionally. We focus our attention on the social
organisation of healthcare professionals’ knowledge and front-line practices,
highlighting the textual processes through which they overrule patients’ concerns
and uncertainties about taking preventative medication, such that some patients
feel unable to openly discuss their health needs in preventative consultations. We
show how healthcare professionals activate knowledge of ‘evidence-based risk
reduction’ to frame patients’ queries as ‘barriers’ to be overcome. Our analysis
points not to deﬁciencies of healthcare professionals who lack the expertise or
inclination to adequately ‘share decisions’ with patients, but to the ways in which
their work is institutionally orientated towards performance measures which will
demonstrate to local and national policymakers that they are tackling the ‘burden
of (cardiovascular) disease’.
Keywords: uncertainty, institutional ethnography, social organisation, cardiovascular disease
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Introduction
In England, as in other economically developed countries, prevention of cardiovascular disease
(CVD) has become a policy priority (NHS England 2014, 2019). In response to newly avail-
able knowledge about the distribution of CVD and its risk factors from epidemiological
research (e.g. Global Burden of Disease project (Lopez et al. 2006)), policymakers have devel-
oped a suite of interventions aiming to reduce CVD mortality and morbidity (Public Health
England 2016a). Such interventions have become established through their inclusion in evi-
dence-based clinical guidelines for healthcare professionals (HCPs) working in general
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practice. They are not only calculated to improve population-level health outcomes but also to
be highly cost-effective. In particular, the pharmaceutical treatment of ‘risk conditions’ (e.g.
hypertension, Type 2 Diabetes Mellitus and hypercholesterolaemia) is projected to accrue sig-
niﬁcant future healthcare savings (Kearney and Freeman 2016) by preventing or delaying dis-
ease onset. The NHS Health Check programme has been developed to support the
preventative agenda through the identiﬁcation and treatment of both risk conditions and life-
style risk factors (Public Health England 2016b).
Using institutional ethnography (IE) (Smith 2005), we explicate CVD prevention as a
‘sphere of activity’ (Smith 2014: 227) that is institutionally coordinated by people working at
the local, national and international level, and that is embedded within the Global Burden of
Disease (GBD) discourse. In IE, ‘discourse’ encompasses texts, talk and activity–and is under-
stood to be a central feature of ruling practice. Its peculiarity is the way that the talk and activ-
ity of those ‘who claim membership’ of it, (ibid. p.229), becomes (at least to a degree)
‘standardised’ (ibid. p.231). Within GBD discourse, talk and activity is coordinated through
epidemiological metrics, and through the statistical outcomes of clinical trials which inform
‘evidence-based medicine’ (EBM). As Adams (2016) writes in her critical analysis of ‘global
health’, such ‘technologies of counting [. . .] are imagined to offer uniform and standardised
conversations about how best to intervene, how best to conceptualise health and disease, how
best to both count and be accountable, and how best to pay for it all’ (ibid., p.6). GBD metrics
in particular add a highly visible and simpliﬁed overlay to what Mykhalovskiy (2001) has, in
a similar vein, called the ‘patterned universe’ of health services research. A small range of per-
formance indicators, representing seemingly neutral accounts of the ‘real world’ (yet laced
with all kinds of politics and managerial imperatives relating to ‘efﬁciency’ and cost savings),
are given prominence within GBD discourse.
Drawing on an IE of CVD prevention in general practice (Cupit 2018), we examine how
socially organised practices of knowledge known as CVD prevention enter the work of HCPs,
and thus the work of patients. We point to the complex, constructed nature of ‘risk’, focusing
on how HCPs utilise risk-scoring technology (Hippisley-Cox et al. 2010, Will 2005)–which
has become central to informing statin-based treatment across populations, and a key compo-
nent of economic models for prevention. We show how risk scoring is being employed in
HCPs’ practice (in the context of Health Checks)–and how this work intersects with, and
shapes, patients’ knowledge and uncertainties about how to improve their health. We explore
how the ‘best’ science, generated systematically from huge epidemiological datasets, large con-
trolled studies, the aggregates of systematic reviews and economic forecasting, actually plays
out in the everyday world of health care. Crucially, we show how the form of knowledge
embedded in the texts and activities of CVD prevention creates a tension for practitioners and
patients–those people whose own knowledge ‘bumps into’ such tidy numerical abstractions.
Statistical generalisations enter a ‘ruling relation’ (Smith 1987: 3) into the subjectivities and
uncertainties of their day-to-day prevention work. Our aim is to show empirically how clini-
cians and patients’ knowledgeable actions (and the embedded elements of uncertainty that
underpin each encounter) are socially organised within the relations of GBD and evidence-
based risk management discourse.
We understand ‘uncertainty’ to be an integral part of the experience of both HCPs and
patients and therefore an inevitable feature of front-line clinical practice. Patients bring the
many ‘viscous variables’ of their lives (Mol 2008: 62) to a clinical encounter, and HCPs are
tasked with responding to these, bringing not only their evidence-based clinical knowledge but
also their ‘tacit, context-bound and ephemeral’ knowledge (Greenhalgh 2013). Employing IE’s
theoretical framework, our conceptualisation of ‘uncertainty’ is allied to knowledge–a key ana-
lytical focus of IE. Patients bring their local knowledge (and uncertainties) of what can be
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done to improve health, the experiences of trying to break unhealthy habits and the many
aspects of everyday life which intersect with these experiences; HCPs bring their own local
knowledge (and uncertainties) about how they can best support patients’ work to improve their
health. ‘Good care’ involves HCPs and patients working together to ‘try, adjust, and try again’
in the light of the many variables, uncertainties and what is possible and/or desirable in the
circumstances (Mol 2008: 22).
The research reported here builds an account of how risk scoring enters front-line consulta-
tions and how it shapes decisions about preventative action–and particularly decision-making
about statins. Our analysis, focused on explicating the organisation behind HCPs’ work (in
the context of decisions about statins), extends the insights of Mol (2008). We explicate how
the work of trying, adjusting and trying again is organised to happen (or not), examining the
socially organised circumstances of everyday practice that shape what is possible. Our analysis
adds to the ﬁndings of Polak (2016), who explored patients’ (un)certainty in relation to statin
decisions. It exposes the social organisation behind her intriguing ﬁnding that many patients
were certain that statins were needed to treat current problems, even though they were actually
treating future risk. It also elucidates the practices which result in patients seeing lifestyle
change as ‘futile’ (Saukko et al. 2012). Additionally, our analysis complements other research
that highlights the value patients place on HCPs’ expertise–trusting them to provide person-
alised advice (see Will and Weiner 2015). Principally, however, our research responds to
Mykhalovskiy and Weir’s (2004) call for research investigating ‘the speciﬁcity, discursive
character and effects of EBM as a practice of knowledge’ in its ‘local and translocal dimen-
sions’. We show how clinicians are organised to selectively activate ideas about evidence-
based management of CVD risk, becoming preoccupied with ensuring that patients take up an
offer of statin medication and neglecting behavioural support (even though this support is also
emphasised in guidelines). We then expand our research gaze to identify the translocal dimen-
sions of EBM and examine its ‘speciﬁcity’ as it arises as a ‘practice of knowledge’ (ibid.)
designed to efﬁciently manage the innate uncertainty and unpredictability of each patient
encounter. It is only when we redirect our gaze into dominant (ruling) relations that we see
the social organisation of this preoccupation; we show how performance measures, orientated
towards reducing the ‘burden of disease’ (in terms of lives and costs saved), are dominant
organisers of HCPs’ front-line work.
Institutional structures for CVD risk management with statin medications
In this section, we introduce the broad discursive terrain of evidence-based risk management
as it arises in people’s coordinated activities of risk scoring and discussions about preventative
medications. Our presentation of various academic and other texts related to CVD risk (and
the related topic of statin medications) is offered less as a ‘literature review’, and more as an
analysis that seeks to make visible the component activities of CVD prevention–activities
which are embedded in the work of people located throughout the broad institutional relations
of CVD prevention.
One of the explicit goals of EBM is to reduce variation in clinical practice through the use
of evidence-based clinical guidelines (Knaapen 2014, Timmermans and Berg 2010). The main
guideline coordinating HCPs’ work to score and manage an individual’s ‘overall risk’ in Eng-
lish primary care is NICE guideline ‘CG181’ (NICE 2014a). Not only does a risk score quan-
tify risk, it also forms the (textual) basis for offering statins (see Will 2005). Since 2009, risk
scoring has been central to the NHS Health Check programme, providing a mechanism for
identifying individuals at high CVD risk. Speciﬁcally, the Health Check is structured around a
© 2019 The Authors. Sociology of Health & Illness published by John Wiley & Sons Ltd on behalf of Foundation for SHIL.
Overruling uncertainty in preventative care 3
prediction of an individual’s chances of a heart attack or stroke over the following 10 years–
calculated using ‘QRISK’ technology (Hippisley-Cox et al. 2010). To enable risk score calcu-
lation, the main NHS Health Check appointment (Part 1), usually delivered by a healthcare
assistant, follows a structured sequence of questions and tests which capture the patient’s basic
demographic data, information about their ‘lifestyle’ and biological ‘markers’ including blood
pressure, cholesterol and sugars (Public Health England 2016b). From this, a single risk score
is produced, expressed as a percentage; CG181 recommends that patients with a risk
score > 10% should be offered statins, and given guidance on healthy behaviours. The term
‘offer’ indicates to HCPs that there is ‘clear evidence of beneﬁt’ for the prescription of statins
and this is a ‘strong recommendation’ (NICE 2014b)–reinforced within the Quality and Out-
comes Framework ﬁnancial incentive system (NHS Employers et al. 2015).
The risk score is usually calculated a few days after the main Health Check appointment,
when blood test results become available, by a qualiﬁed nurse or a GP. This moment, when
the risk score is calculated and high risk patients contacted (Part 2 of the check), is the point
where we begin our explication of the institutional complexes that coordinate the administra-
tive regime of CVD prevention practices; it is also where issues of certainty and uncertainty
arise. The risk score brings GBD’s statistical knowledge into the clinical encounter as a single
text–a representation of the patient’s various risk factors, calculated to guide action. The poten-
tial challenges of communicating statistical knowledge are recognised within the guideline,
which includes many additional recommendations about how risk statistics should be commu-
nicated (e.g. using visual prompts).
There has been much debate about the beneﬁts and harms of statins within clinical, aca-
demic, and (subsequently) public arenas. Some GP opinion leaders have, for example, pro-
posed that HCPs who slavishly follow guidelines and the mathematical modelling of risk may
be responsible for patients being ‘over-treated’ with statins (e.g. McCartney 2012, Price 2014).
Fierce debate on the quality of the evidence for prophylactic use of statins in the pages of the
Lancet and the BMJ was dubbed the ‘statin wars’ (Husten 2016). Campaigners have also high-
lighted that, for some patients, behavioural change may be a reasonable alternative to medica-
tions, and more in line with patient preferences (e.g. Unwin and Tobin 2015). Within this
discursive terrain, although CG181 was developed in response to evidence about statins, it also
strongly advocates both the promotion of behavioural change, and the principles of patient
involvement, shared decision-making and patient-centred care–all of which emphasise the
importance of patients’ values and preferences in good-quality care. Ultimately, HCPs have to
determine how to activate these parallel textual directions for both ‘best treatment’ and ‘shared
decision-making’ in the complex world of patient care. And it is here, in clinical practices,
where knowledge disjunctures arise–who knows what and whose knowledge ‘rules’. It is this
social organisation of decisions about statins which we examine more closely.
Methodology
This article draws on an IE of CVD prevention in general practice. Ethical approval was
granted by the Liverpool NHS Research Ethics Committee (ref. 15/NW/0883). IE is an estab-
lished ‘mode of enquiry’ (DeVault and McCoy 2006: 16) developed by Dorothy E Smith
(1987, 2005). At its heart is a concern with the social organisation of people’s knowledge and
work. It is a method to investigate the ways people’s activities (and knowledge of what to do)
are coordinated by texts which embed interests generated at a distance from the local setting,
often with troubling effects. These forms of coordination are reproduced repeatedly across dif-
ferent times and places (Smith 2005), often through textual technologies which allow particular
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forms of knowledge to be standardised and spread from one location to another. The IE
approach is particularly useful in revealing tensions between what is known from a local expe-
rienced position (known as a ‘standpoint’ in IE) and what is known from a translocal, ruling
position (an ‘institutional’ perspective). It is important to note here that the term ‘institution’ is
not synonymous with ‘organisation’ in IE, but refers to ‘processes that stretch across time and
place to coordinate people’s activities’, which are interconnected around a speciﬁc function
such as health care (Bisaillon 2012). The IE approach aims to map the tangible relations that
establish how social settings are organised. In particular, an IE enquiry explicates ‘ruling rela-
tions’–those practices that contribute to privilege or subjugation for those people for whom the
research is conducted (the standpoint location). While not widely used within the sociology of
health and illness, examples of IE in this ﬁeld include studies of: the work involved in adher-
ing to medication regimes (McCoy 2009); the use of research evidence within multidisci-
plinary teams (Quinlan 2009); and how electronic health records shape nursing work
(Campbell and Rankin 2016).
The study contained multiple elements including: 24 interviews with patients who had at
least one CVD ‘risk factor’; nine interviews with front-line HCPs (GPs, Practice Nurses, and
Healthcare Assistants); observations of preventative interactions, especially NHS Health
Checks (32 hours); and 14 interviews with other ‘extralocal’ participants who could inform
particular aspects of the enquiry (e.g. local NHS Health Check commissioners). Because the
IE approach aims to map social organisation (rather than, for instance, generate ‘themes’ or
‘theory’ from participant samples), a purposive approach was taken to recruiting informants;
they were carefully selected in relation to their familiarity with the work processes and texts
under investigation. Congruent with this goal, the study also incorporated extensive collection
and analysis of documents (e.g. policy, economic analyses, clinical guidelines).
During data collection, Part 1 of the Health Check was easily observed. Part 2 (the focus of
this analysis) was more complex because the processes were embedded into a variety of rou-
tine clinic work (most often general appointments or telephone consultations). To develop an
accurate account of the work involved in Part 2, we therefore relied primarily on interview
data. Reliance on interviews as the main (or only) form of data is often necessary in IE analy-
ses where access for ethnographic observation is difﬁcult, but is undoubtedly a limitation.
However, using IE’s distinctive approach to interviewing (DeVault and McCoy, 2001), we
focused on the sequences of action involved in the Part 2 consultation, seeking to avoid the
collection of ‘professional accounts’ which would be far-removed from observable practice.
Guided by Campbell and Gregor’s (2002: 77) advice that ‘the test of whether you are getting
a professional account as opposed to an account of what actually happened is if you, the lis-
tener, cannot see every step without having to imagine pieces’, informants were asked to walk
through what they did and said in consultations in order to discuss risk and statins with their
patients. Notably, these accounts of their practices closely reﬂected patient accounts of what
happened, and observations of other preventative consultations.
From in-depth conversations with patients who described how their experiences unfolded,
and from observations of preventative care in practice, we learned about speciﬁc troubles.
Although diverse and individually unique, these troubles highlighted gaps between what
patients (and HCPs) knew from an experiential perspective and what they knew from a ruling
perspective–and established our analytic purpose. These tensions guided us to ‘direct attention
to a possible set of questions that [were] yet to be posed, [and] puzzles that [were] not yet for-
mulated as such but [were] ‘latent’ in the actualities of [people’s] experienced worlds’ (Smith
1987: 89)–a process known in IE as ‘formulating the problematic’. The research standpoint
was aligned with patients. This standpoint location within the social organisation of CVD pre-
vention provided ‘a guiding perspective’–starting with the ‘issues, concerns or problems that
© 2019 The Authors. Sociology of Health & Illness published by John Wiley & Sons Ltd on behalf of Foundation for SHIL.
Overruling uncertainty in preventative care 5
[were] real for people and that [were] situated in their relationships to an institutional order’
(Smith 2005: 32).
Formulating the problematic
The study problematic brought together multiple disjunctures identiﬁed–gaps between what
patients (and HCPs) knew from an experiential perspective and what they knew from a ruling
perspective. For the purpose of this article, we offer an example of such a disjuncture (selected
for its relevance to decision-making about managing risk with statins). We present this disjunc-
ture using two data excerpts which we employ as orientation for the more detailed empirical
analysis to follow. The ﬁrst is taken directly from ﬁeldnotes of an observation and subsequent
interview with a patient, ‘Sarah’, who had accepted an offer of statins. The second is from an
interview with a GP, ‘Dr Abel’, who highlights that statins are clinically indicated following
the calculation of a high risk score.
Sarah
I met Sarah [patient] when observing her ‘diabetic review’. Sarah had been prescribed a statin
following a diagnosis of Type 2 Diabetes Mellitus (the diagnosis increases an individual’s cal-
culated CVD risk)–she understood that the statin was one element of the recommended treat-
ment. However, after a while, she became so depressed with her declining wellbeing, which
included side-effects from Metformin (a diabetes medication), that she abandoned the statin
when friends suggested that it too could also be contributing to her symptoms. During her dia-
betic review, the practice nurse proceeded through the review template, including double-
checking that Sarah was taking the statin. Sarah quietly pointed out that she had stopped doing
so, but seemed to avoid a discussion about her reasons for her unilateral action. Afterwards,
Sarah told me that she had been reluctant to raise the issue because she thought that the nurse
would be unlikely to support her course of action; Sarah understood that the clinical relation-
ship on which she relied could suffer if she contravened advice. She emphasised that she had
not taken the decision lightly but that “it’s the quality of life that counts”. She was keen to ﬁnd
ways of managing her diet and exercise to support this aim.
This short account of Sarah’s experience highlights how one patient was concerned about taking
statins (in this case, after taking them for a while, rather than when offered following a high risk
score). She knew that they were the recommended treatment, but she also knew that they might
be contributing to symptoms she found difﬁcult to bear. She hesitated to discuss her concerns
with the nurse for fear of undermining the relationship; the nurse (Lydia), on whose interview we
draw later, also appeared to have little interest in pursuing a conversation. Sarah’s uncertainties
about the value of statins and the symptoms she was experiencing remained undiscussed within
her clinical care. This disjuncture in Sarah’s account orientates our analysis here.
The second excerpt is chosen because it shows how HCPs know to discuss statins with a
patient, and how this is textually organised around the categorisation of a patient as ‘high
risk’. It is an additional ‘view from the ground’ into the problematic we are explicating.
Dr Abel
If the risk is high then we would need to contact [the patient] to discuss whether they are
willing to be on a statin.
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Dr Abel knows that ‘if the risk is high’ (i.e. risk-scoring technology calculates that the
patient has a 10% or greater chance of a heart attack or stroke over the following 10 years
(NICE 2014a)) she should offer statins. Her response to the risk score is similar to any other
test result such as a high blood pressure reading. She treats the risk technology as a tool to
classify disease (see Jutel 2011), for which the recommended treatment is a statin. Her synop-
sis of what she should do (she needs to check whether the patient is ‘willing’) is in line with
evidence-based recommendations in authoritative guidance (CG181). From a fuller analysis of
Dr Abel’s account, it is clear that she understands herself to be ‘following the guideline’ and
that her goal therefore is not only to offer statins but, if possible, to ensure that the patient
takes up this offer. She knows that a statin is the evidence-based course of action, which is
likely to beneﬁt her patient (see ‘institutional structures for CVD risk management’ above).
The two excerpts above illustrate a disjuncture between patients’ individual knowledge (and
uncertainties) about how statin medications can be incorporated into their health improvement
work, and what we are describing as institutional or ‘ideological’ knowledge. According to
Smith (1987: 55), ideology consists of ‘ideas and social forms of consciousness [which] origi-
nate outside experience, coming from an external source and becoming a forced set of cate-
gories into which we must stuff the awkward and resistant actualities of our worlds’. Such
conceptual forms of knowledge (and the practices which are inextricably linked to them) ‘deny
expression to the actual experience people have in the working relations of their everyday
world’ (ibid.). When people act according to an institutional knowledge which is at odds with
their (or others’) local, embodied experience, this can be described as ‘ideological practice’.
We highlight ‘ideological’ knowledge and practices as we progress this analysis.
Disjunctures such as that highlighted above raised questions that contributed to the formula-
tion of the problematic (the tensions to be described and explicated). Questions included:
‘How is it that patients struggle to bring uncertainties about preventative technologies (e.g. sta-
tin medications) to the attention of HCPs, and have these attended to?’ ‘What is the social
organisation of guidelines’ directions for ‘shared decision-making’?’ ‘How do these enter into
HCPs’ work?’ ‘And in whose interests?’ As we explicate this problematic, we explore a ‘par-
ticular corner’ within the institutional complex of CVD prevention, to make visible the ‘points
of connection with other sites and courses of action’ (DeVault and McCoy 2006: 17). We
explore how HCPs activate institutional knowledge of CVD risk and evidence-based risk man-
agement in Health Check consultations, and how this intersects with the work of patients who
feel unsure about raising their uncertainties about preventative medications with HCPs.
Activities of evidence-based risk management: guidelines, uncertainty and informed
decisions
As we have outlined, the risk score is an important text within the institutional structures of
CVD prevention and particularly in the Health Check, which is structured around its calcula-
tion. Pertinent to this analysis is how the texts embedded in the Health Check are organised to
abstract each patient’s ‘lifestyle’, biological and socioeconomic particularities into a category
of ‘overall risk’. The data collected, as directed by an electronic template, are subject to a
behind-the-scenes algorithmic calculation, based on aggregated data from epidemiological stud-
ies. We note therefore that practices of delivering the Health Check are designed to separate
individuals from the unique circumstances of their lives; that is, they are ‘ideological’ in the
sense used in IE. This ideological knowledge, on which the risk score and the recommendation
to offer statin treatment are based, provides a position of ‘certainty’ from which HCPs work to
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introduce discussions of CVD risk and preventative medications. In the following extract, Dr
Sully (a GP) exempliﬁes such certainty:
The evidence behind what we do is absolutely top drawer [. . .] no one would argue [. . .] so
you know, it’s about having a conversation with a patient and saying ‘these are the guideli-
nes, we know this works, these are the beneﬁts and these are the risks, you decide’.
Dr Sully understands that it is his responsibility to communicate to his patients that preventative
medications ‘work’–in other words that they will prevent heart attacks and strokes. Despite the
complexity of the evidence base, and its ambiguous relevance for his individual patient, Dr Sully
conﬁdently brings abstracted knowledge about population health to the encounter. The knowl-
edge he activates has become binary in its guideline form: an individual is ‘at risk’, or ‘not at
risk’. Similarly, interventions either ‘work’ (and are recommended in guidelines), or do not
‘work’ (and are omitted from guidelines). In Smith’s (2005: 18) terms, both Dr Sully’s ‘con-
sciousness’ and his practices (the way in which he communicates to his patients) are shaped
through his reading of guideline texts. He trusts the institutional processes of guideline develop-
ment to provide him with clear-cut knowledge of risk and of ‘what works’, and he draws on
EBM’s established narrative to emphasise the certainty of this knowledge when he speaks with
his patient. For him, this is the requisite ‘knowledge for taking action’ (Rankin and Campbell
2006: 7)–the textual certainty which allows him to move quickly to statin prescription. The
uncertainties–what beneﬁt might be gained for a particular patient–recede from his view.
The scientiﬁc knowledge of risk and preventative treatments jars with the uncertainties of
front-line clinical encounters–and in the work of both patients and HCPs. This disjuncture is
in Sarah’s quiet, almost surreptitious act of terminating her use of statins, and in Dr Abel’s
description of her work to cultivate a patient’s willingness to take them. Risk scores, as noted
above, bring a person’s whole life into view as a single measure of CVD risk. How then can
HCPs make this standardised and remotely calculated knowledge meaningful to an individual
patient? CG181 responds to these difﬁculties by providing extensive guidance on how risk
should be ‘communicated’ to patients–a plethora of directions that augment the recommenda-
tion to prescribe statins for all patients who exceed the 10% risk threshold. These include
advice to allow ‘adequate time’ and to use easy-to-understand language and visual tools that
provide a simple way to illustrate and explain risk statistics. The guideline emphasises that:
the decision whether to start statin therapy should be made after an informed discussion
between the clinician and the person about the risks and beneﬁts of statin treatment, taking
into account additional factors such as potential beneﬁts from lifestyle modiﬁcations,
informed patient preference, comorbidities, polypharmacy, general frailty and life
expectancy (p.17).
However, despite these explicit directions and the tools provided, the HCPs we interviewed
found the epidemiological probabilities difﬁcult to explain to patients, and consequently
steered away from such explanations of risk. When they attempted to bring this form of
knowledge to their patients, tensions arose; discussions did not unfold in the straightforward
way that the directions and tools are designed to support:
It’s hard to give people these ﬁgures because it’s a bit of an abstract concept [to tell some-
one] ‘you’ve got 21% risk of getting a heart problem in the next 10 years’. For some people
that might seem very low and others . . . (Dr Abel, GP)
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I don’t think [HCPs] talk about risk [. . .] Most patients are innumerate. If you say to some-
body, ‘You’re at 30% ten-year risk’, they don’t understand. Scarily, substantial numbers of
doctors don’t understand. (Dr Smart, GP)
Although presented here as a problem of statistical competence (of both patients and HCPs),
our data show that the tensions arising in front-line practice are more troubling than issues of
numeracy. The abstract, scientiﬁc knowledge of risk scoring creates new work for HCPs
tasked with bringing it into an individual consultation. Lydia describes the work she under-
takes to make a risk score and statin treatment meaningful to her patients:
I have to explain that [the risk score’s] looking at your blood pressure, it’s looking at your
weight, it’s looking at your sex, it’s looking at where you live, it’s looking at your family
history, it’s looking at your cholesterol. So [cholesterol’s] just one marker. (Lydia)
Lydia provides an overview of the types of data included, and how demographic factors (such
as sex, neighbourhood and family history) and clinical markers (blood pressure and cholesterol
levels) produce an all-encompassing and authoritative score. She notes that helping patients
understand risk scoring is made particularly difﬁcult by the recommendation to treat a high
risk score with statins even when the patient does not have an elevated serum cholesterol.
Although based on trial evidence that cholesterol-lowering is beneﬁcial whatever the baseline,
this knowledge is counter-intuitive for patients. Similarly, Dr Abel describes how patients also
raised other concerns about taking statins, demonstrating disjunctures between their own
knowledge and that of epidemiology and evidence-based risk management:
Some patients are very keen to have [statins] because they’ve heard that it helps to reduce the
risk of heart events and stroke [laughs]. Others have heard some of the more negative publicity
about statins, or they’ve had a relative who’s been on them and had bad leg-ache, for example,
and don’t want them. Some people want to try diet and exercise ﬁrst. (Dr Abel)
The HCPs reported that patients regularly raised such queries, preferring to avoid statins if possi-
ble (as Will and Weiner (2015) have similarly shown), and bringing knowledge from debates
aired in ﬁelds beyond medicine (e.g. news media) (see Stevenson et al. 2003), in support of this
alternative knowledge rooted in the ‘actualities of [their] worlds’ (Smith 1987: 55). For instance,
patients asked about side-effects (which were anecdotally reported to be much more prevalent
and severe than suggested by guidelines), or whether they could address their high risk score by
making dietary or exercise changes alone (recognising that important aspects of their health such
as obesity would not be solved by taking a statin). When they asked such questions, patients
were not primarily wishing to engage in complex discussions of the research evidence, but were
interested in its application to the particularities of their own lives. With regard to the science
itself, they appeared more comfortable trusting their HCPs’ judgement about whether statins
would be a good idea in their situation, within the context of their own everyday life and prefer-
ences. One patient encapsulated his uncertainty with a question (which he hoped his GP would
answer): ‘Does it make sense [for me] to take a statin?’ HCPs like Dr Abel and Dr Sully, how-
ever, resolutely drew on a narrative of EBM to answer this sort of question with certainty. Sta-
tins, within the scientiﬁc form of knowledge espoused by EBM, ‘make sense’ for all patients
with a high risk score: they ‘work’. Rather than working with the patient to explore whether a
statin would ﬁt with their individual circumstances, HCPs described how they actively promoted
compliance as the foundation of their responses to patients. They framed the reluctance that
underpinned patients’ queries as a ‘barrier’ to the expected course of action:
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You have the barriers to start breaking down. So it’s ‘What do you know about statins?’
‘What have you heard about statins?’ ‘How would you feel about taking them?’ And then
you explain to them what the side-effects are. If they have the side-effects then let me know
because I will stop the tablets. It’s up to them, they don’t have to take them if they don’t
want to. It’s going to reduce their risk, but I can’t say for deﬁnite that it means that they
won’t have any problems. It has to be their choice. (Lydia, Practice Nurse)
Lydia, like Drs Abel and Sully, persuades her patients to accept preventative medication
through a process of identifying, and then breaking down, their ‘barriers’–correcting what
appear to her to be their misconceptions. It is at this point of potential non-compliance that
she employs techniques represented in CG181 and other guideline texts as strategies to ‘in-
volve’ the patient. Delivered as simple one-liners (e.g. ‘What have you heard?’), Lydia’s ques-
tions help her to meet multiple institutional requirements; she understands her pithy
questioning to both ‘involve’ the patient, and also to keep the patient on course for a medica-
tion prescription. She is focused on medication adherence even as she recognises that the
patient may have ‘problems’, and that trying to overtly pressurise patients is likely to be coun-
terproductive.
Although our data suggest that HCPs make efforts to encourage patients to modify their life-
style behaviours (usually with short questions and prompts during Part 1 of Health Check pro-
cess), HCPs undertaking Part 2 (the conversation about risk and statin medications that we are
explicating here) are careful to ensure that patients are not derailed from a medication-oriented
course of action. Dr Abel reported for instance that, while keen to highlight particular lifestyle
risks and (rhetorically) encourage patients to make changes, she is also careful to ensure that
they do not put their hopes in lifestyle change as a potential alternative to medications–that
they are not distracted by attempting to ‘try diet and exercise ﬁrst’ (earlier excerpt). Whilst she
is attentive to CG181’s directions that she should ‘discuss the beneﬁts of lifestyle modiﬁcation
and optimise the management of all other modiﬁable CVD risk factors’ before offering a sta-
tin, she simultaneously undertakes to ‘warn people that [lifestyle change] doesn’t always
work’–putting them off a course of action which might seek to bypass medications. After a
patient is classiﬁed as being at ‘high risk’, lifestyle change is no longer the primary focus of
her prevention work. Her own account indicates that such discussions are shaped by a knowl-
edge framework which prioritises the prescription of preventative medications above such life-
style action.
Absorbing professionals into the ruling relations of CVD prevention
As we have shown, the discursive practices of risk management embedded within the institu-
tional structures of EBM strongly organise HCPs’ front-line work–to the extent that their work
to manage risk using medications dominates over other work to meaningfully ‘involve’ the
patient and to support behavioural change–even though this is also promoted within CG181.
To grasp how this organisation works, we scrutinise HCPs’ practices to apprehend the tensions
generated within the prominent discursive terrain of ‘patient-centredness’ and ‘shared decision-
making’. The HCPs on whose accounts we have drawn all emphasised that patients are not
compelled to take medications. Dr Sully, when gently challenged that a patient might feel
coerced into starting medications, strongly disagreed: ‘the idea to suggest that we’re there to
push medication is stupid, and I don’t accept that at all’. However, we note that, simply by
providing an option to reject the guideline recommendation (see earlier excerpt), he could
frame his practice as ‘sharing decisions’ with patients; he had shared the authoritative and
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standardised information on beneﬁts and risks and it was now down to the patient to ‘decide’.
However, rather than a collaborative process in which patient and HCP work together to iden-
tify the best course of action for the individual patient, the ‘discussion’ has become a transac-
tion, and (even from these HCPs’ own accounts) it appears that such interactions offer little to
help patients manage the uncertainties and problems thrown up by the risk score.
As HCPs drew their patients into actively ‘choosing’ the institutionally sanctioned course of
action (seemingly overruling patients’ queries and uncertainties) they simultaneously used lan-
guage such as ‘patient-led’, ‘communication’, ‘involvement’ and ‘shared-decisions’, thereby
constructing a belief that they were enacting these patient-focused values. However, the lan-
guage of ‘patient-centredness’ and ‘shared decision-making’ used by HCPs conceals the ruling
relations of CVD prevention; such ‘involvement’ work brought with it the institutional agenda
of compliance with standardised forms of risk reduction whereby ‘involving’ patients is sup-
posed to result in ‘better decisions’ through which patients are understood to be “more likely
to adhere to their chosen treatment plan’ (NICE 2014c: 82). Smith (2005: 155) describes this
shaping of people’s consciousness in line with ruling relations as ‘ideological (or institutional)
capture’, in which people (research participants, researchers or others) draw on institutional
discourse to displace their own understanding of what is happening. Ideological capture works
to blind people to what is going on. Although they may experience some disjuncture (Camp-
bell and Gregor, 2002), they may nonetheless gloss over such moments, treating tensions as
an ordinary, acceptable feature of doing good work. HCPs’ ‘captured’ understanding of
patient-centeredness clashes with patients’ difﬁculties with discussing their uncertainties about
their health needs and the relevance of statins. Their work overlooks patients’ anxieties and
struggles with improving their health, especially for those patients with unhealthy ‘lifestyles’,
towards whom CVD prevention interventions are particularly aimed.
The complex of social relations organising preventative decisions: monitoring CVD
prevention through GBD metrics
So far, we have focused on the risk score and an institutionally constructed rhetoric of shared
decision-making as components of the textual organisation which shapes preventative care. We
have highlighted some of the tensions between authorised knowledge of risk management and
patients’ own understanding of what they need to improve their health, and particularly their
desire for support with addressing their uncertainties about statin medications. We have drawn
attention to the ‘everyday’ practices of HCPs that reinforced the authority of ideological
knowledge in preventative consultations–practices that are detrimental to their relationships
with patients. We have noted that HCPs may become so focused on evidence-based risk man-
agement with medications that they forfeit attention to patients’ experiences of improving their
health and sidestep their concerns and uncertainty about what to do–even whilst understanding
themselves to be ‘involving’ patients. We have explicated these tensions as a feature of how
ruling relations are activated–turning a patient’s body into epidemiological information and
rendering it as a ‘case’ (as we elaborate below) that can be turned into quality ‘outcome’ met-
rics to demonstrate the success of CVD prevention.
In this ﬁnal section, we shift our gaze towards the broad textual relations of Health Checks,
risk scores and CVD prevention guidelines. We follow threads of analysis into the governance
of health care in England and beyond–into the institutional structures of the GBD discourse.
IE’s focus on institutional ruling relations shifts the focus of analysis from a critique of indi-
vidual HCPs (who may be accused of slavishly following guidelines, for instance), to examine
instead how HCPs’ attentiveness to particular recommendations is coordinated within an
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‘intertextual hierarchy’ (Smith 2006: 79), dominated by what Adams (2016: 6) describes as
‘technologies of counting’. At their highest level of abstraction, these technologies supply
apparently neutral knowledge about the ‘burden of disease’ and what should be done to reduce
that burden.
In England, Clinical Commissioning Groups (CCGs) are part of the complex organisational
structures which govern healthcare provision. An informant interview with Luis (a commis-
sioner) provided a clue into how the Health Check generates metrics of risk condition preva-
lence (including overall risk), evidence-based treatment (e.g. statins) and CVD outcomes that
organise HCPs’ work with their patients. He explained:
From a CCG monitoring point of view, the main output [from the Health Check
programme] is the number of Health Checks delivered, but it also feeds into things like
concerns about prevalence of long-term conditions [as measured through GP electronic
systems]. So we would be interested in the number of new patients diagnosed with diabetes,
for example, or the number of new hypertensives identiﬁed and started on evidence-based
treatment. [. . .] That is part of a structured, iterative approach in primary care to ascertain
new cases, managing them early, and we know from a CCG point of view, that there is a
relationship between managing hypertension well, ﬁnding new hypertensives [. . .], and a
reduction in terms of early mortality and morbidity from things like stroke, MI and so
forth. (emphasis added)
Here, although Luis does not talk explicitly about the ‘burden of disease’, he understands that
measures of the prevalence and treatment of risk conditions are important proxies for how
effectively local managers are tackling the burden of disease (in terms of both lives and costs
saved)–measures which would be highly visible to national CVD prevention policymakers
(e.g. Public Health England 2015). Our data show that local policymakers’ work was tightly
oriented to the GBD ‘sphere of activity’ highlighted in our introduction–coordinated work and
talk focused on statistical measures of disease burden (see, for example, Department of Health
2013; Newton 2017), which were also translated into projected cost savings (Kearney and
Freeman 2016). Local policymakers in turn drew front-line HCPs into this focused activity to
address their local burden of disease–monitoring proxy measures such as risk condition preva-
lence (health centres with a high recorded disease prevalence are understood to be doing well
at identifying ‘new cases’) and the pharmaceutical treatment of those newly identiﬁed risk con-
ditions. Through benchmarking and variation modelling, general practices across regions were
compared, and the lowest performers targeted for improvement interventions.
Within the constraints of this article we cannot explicate in detail how such performance
measures enter into HCPs’ everyday work or how, in practice, HCPs’ work to ‘try, adjust, and
try again’ in the face of multiple uncertainties (Mol 2008: 22)–to ‘care’–is sometimes ‘organ-
ised-out’ of preventative interactions. However, GP informants in this study described how
they were acutely conscious of the way in which select CVD performance measures are moni-
tored and made publicly visible. It was these measures that coordinated attention within gen-
eral practice to making ‘adjustments’ to data in preparation for governance scrutiny. They
explained that they were not only ﬁnancially incentivised to identify and treat CVD risk condi-
tions through the Quality and Outcomes Framework (Cupit 2018; NHS Employers et al. 2015,
Appendix 4), but, for some, more importantly, their reputations were at stake as local policy-
makers used the data to judge GPs’ performance. This explication of how patients’ frustrations
and uncertainties are organised shows how managers and front-line HCPs are increasingly
drawn into tightly focused work in which a limited set of measures are understood to provide
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knowledge of what happens locally; that representation is concurrently used to drive action
directed speciﬁcally towards improving those measures.
Institutional ethnographic researchers have described the circular forms of action such as
those described above as ‘accountability circuits’ (Grifﬁth and Smith 2014: 10). The circular
accountability practices of CVD prevention are produced by multiple, interrelated textual pro-
cesses which, we argue, are orientated towards quantiﬁably reducing statistical measures of the
‘burden of disease’. They include economic modelling processes which shape the way preven-
tative care is fragmented across different HCP roles. Such accountability practices have conse-
quences which, although apparently unintended, are socially organised to happen as they do.
The scrutiny imposed on health centres’ electronic health records organises HCPs to systemati-
cally overlook the very many uncertainties of patients’ individual health needs, and what might
be gleaned during HCPs’ front-line interactions (their ‘clinical judgement’). It directs them
instead to promote adherence to pharmaceutical interventions in favour of ongoing adaptive
support for improving health more broadly. As Dr Smart, for instance, admitted, ‘the tempta-
tion is there to push people to do stuff that you wouldn’t feel you need to do’. This may have
signiﬁcant detrimental consequences for therapeutic relationships between HCPs and patients,
and limit the opportunities for genuine support for patients’ lifestyle change.
Discussion
Our analysis started with the work (and the tensions) as experienced by patients. We used the
empirical tools of IE to explicate how CVD knowledge is organised–how it arises as a ruling
relation inside front-line practices (in which HCPs introduce concepts of CVD risk and risk
management), and subordinates genuine shared decision-making. HCPs activate a narrative of
evidence-based risk reduction as a ‘practice of knowledge’ (Mykhalovskiy and Weir 2004),
which evokes (ideological) certainty in their preventative encounters with patients. Organised
to selectively draw on this narrative, HCPs preserve the ‘dualism between disease and non-dis-
ease’ which Jutel and Nettleton (2011) have previously claimed was ‘collapsing in the face of
new categorisations of potential disease and risk factors’. They overrule uncertainty in the clin-
ical encounter and instead outsource the work involved in managing the uncertainties about
risk diagnoses, pharmaceutical treatments and other preventative options (such as lifestyle
change) to patients–to be managed within whatever private networks and resources are avail-
able to them, away from the clinical encounter.
Our analysis highlights how HCPs’ presentation of particular forms of preventative action
(and their beliefs that these actions are incontrovertibly beneﬁcial) creates difﬁculties for
patients, adding to the ‘work of patienthood’ (May et al. 2014). Our analysis therefore also
provides an explication compatible with the analyses of others who have studied patients’
understanding of risk or uncertainty. For instance, Polak (2016) found that many patients
understood statins to be ‘needed’ to treat a current condition (not a modelling of risk), and
Saukko et al. (2012) highlighted the role of risk assessment technologies in patients’
approaches to medications and alternative courses of action. We have explicated how patients’
practices of knowledge (e.g. how they think about the present and the future, how they make
decisions about medications, or understand the relevance of lifestyle change) are powerfully
shaped through their socially organised interactions with HCPs–whose ruling knowledge about
risk and risk management subordinates other locally situated knowledge and individual dilem-
mas about what to do. We bring attention to how risk assessment technologies enable the con-
ceptual textualisation of a patient’s individual health needs as ‘risk’–a concept that is then
used in aggregate, to demonstrate and drive improvements in highly selective ‘burden of
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disease’ measures. This is how concepts associated with GBD and evidence-based risk man-
agement land into clinical encounters as (ideologically generated) tensions and contradictions–
coordinating individual HCPs’ knowledge and capacity for action. Throughout this article, our
argument is not to show that risk scores, evidence-based treatments or performance measures
related to demonstrating reductions in the burden of CVD are ‘bad’, but to show how they
powerfully coordinate people’s activities, their energies and their consciousness (from policy-
making to the frontline) in ways that, paradoxically, within a rhetoric of shared decision-mak-
ing and concern to support behavioural change, preclude HCPs’ capacity to respond to the
subjectivities and uncertainties of individual patients–to ‘care’. Although many authors have
challenged the role and impact of performance measures, this study is unusual in that it begins
a process of mapping and tracking how the ‘conceptual practices of power’ (Smith 1990) enter
front-line clinical practice–how they are produced and reproduced as textual (empirical and
material) organisers that obscure a robust analysis about what is actually happening in patients’
encounters with HCPs, and how these encounters undermine patients’ attempts to improve
their health within the everyday contexts of their individual lives.
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